NCT03336372View on ClinicalTrials.gov

Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients

EARLY_PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

December 20, 2017

Primary Completion Date

September 8, 2018

Study Completion Date

October 16, 2018

Conditions

Molluscum Contagiosum

Interventions

DRUG

Picato

Picato 0.05% or 0.015% topical gel applied nightly for 3 consecutive nights

Trial Locations (1)

77004

Center for Clinical Studies, Houston

Sponsors

Lead Sponsor

Center for Clinical Studies, Texas

Collaborators (1)

All Listed Sponsors

collaborator

LEO Pharma

INDUSTRY

lead

Center for Clinical Studies, Texas

OTHER